Intrinsiqs

Is Bright Minds Biosciences Inc. overvalued?

Bright Minds Biosciences Inc. (DRUG) — key valuation metrics and fundamentals.

No verdict
Price
$23.11
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$228.0M
Dividend yield
0.0%
Return on equity
-12.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DRUG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.